Form 4: HealthEquity CFO Disposes Shares for Tax Liability
Insider Transaction Report
HealthEquity's EVP & CFO, James M. Lucania, disposed of 2,470 shares of common stock at a weighted average price of $95.236 in a pre-planned transaction.
Summary
- James M. Lucania, Executive Vice President & Chief Financial Officer of HealthEquity, Inc. (HQY), reported a disposition of common stock.
- The transaction occurred on January 9, 2026, and involved 2,470 shares of HealthEquity common stock.
- The shares were disposed of at a weighted average price of $95.236 per share, with prices ranging from $95.2359 to $95.2365.
- This disposition was made pursuant to a Rule 10b5-1(c) pre-planned contract, instruction, or written plan.
- Following this transaction, James M. Lucania beneficially owns 84,566 shares of HealthEquity common stock directly.
Sentiment
Score: 5
Explanation: The filing reports a routine, non-discretionary disposition of shares by an executive to cover tax liabilities, which is a common occurrence upon the vesting of equity awards and does not inherently reflect positive or negative sentiment regarding the company's future prospects.
Future Outlook
This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.
Industry Context
This filing is a routine insider transaction report and does not provide information directly related to broader industry trends or competitive landscape. It reflects an individual executive's stock activity rather than a strategic company announcement.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Insider Trading Policy Adherence | The reported transaction was made pursuant to a Rule 10b5-1(c) contract, instruction, or written plan. This indicates the transaction was pre-planned to comply with insider trading regulations. | 01/09/2026 | The use of a 10b5-1 plan demonstrates adherence to corporate governance best practices regarding insider trading, providing an affirmative defense against claims of trading on material non-public information. |
Stakeholder Impact
- Shareholders: The disposition of 2,470 shares by a key executive is a routine event, typically for tax purposes, and is unlikely to have a material impact on the company's stock price or shareholder value.
Key Dates
| Date | Description |
|---|---|
| 01/09/2026 | Date of transaction where 2,470 shares of common stock were disposed. |
| 01/13/2026 | Date the Form 4 was signed by James Lucania. |
Keywords
HealthEquity, HQY, Insider Transaction, Form 4, Stock Sale, James Lucania, CFO, 10b5-1 Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.